Motley Fool Premium
  1. Stocks
    2. /
  2. GSK (LSE: GSK)
    3. /

LSE:GSK (GSK)

About GSK

GlaxoSmithKline is one of the worlds leading pharmaceutical research companies. The company was created out of the merger between GlaxoWellcome and SmithKline Beecham in 2000.
Financial Market Data copyright © 2026 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.

GSK (LSE: GSK) Latest News

Man smiling and working on laptop
Investing Articles

2 last-minute FTSE 100 shares I’m considering buying before the ISA deadline

| Royston Wild

These FTSE 100 shares could be too cheap to miss, according to our writer Royston Wild. Here's why they're on…

Read more »

GSK scientist holding lab syringe
Investing Articles

Is GSK’s share price set to soar on a new cancer drug?

| Simon Watkins

New drugs lines may boost GSK’s share price even further, but even without these, the business looks very undervalued against…

Read more »

Young woman holding up three fingers
Investing Articles

I’m itching to buy these 3 hidden FTSE gems in a Stocks and Shares ISA

| Harvey Jones

Harvey Jones is keen to add these three FTSE 100 companies to his Stocks and Shares ISA before April. Only…

Read more »

GSK scientist holding lab syringe
Investing Articles

Despite being around an 18-month high, GSK’s share price looks cheap to me

| Simon Watkins

GSK’s share price has risen over the past 18 months, but it still looks undervalued against its peers, and new…

Read more »

Young woman holding up three fingers
Investing Articles

Just released: our 3 top income-focused stocks to buy before March [PREMIUM PICKS]

| Mark Rogers

Our goal here is to highlight some of our past recommendations that we think are of particular interest today, due…

Read more »

Young Asian man drinking coffee at home and looking at his phone
Investing Articles

At £16.70, I think this FTSE 100 stock could be 24% undervalued!

| Royston Wild

The GSK share price offers sector-leading value at current prices. Royston Wild explains why the FTSE 100 stock is on…

Read more »

Couple working from home while daughter watches video on smartphone with headphones on
Investing Articles

2 contrasting FTSE income stocks investors should consider snapping up!

| Sumayya Mansoor

Income stocks paying dividends are an enticing prospect. Our writer breaks down two options for investors to take a closer…

Read more »

A handsome mature bald bearded black man in a sunglasses and a fashionable blue or teal costume with a tie is standing in front of a wall made of striped wooden timbers and fastening a suit button
Investing Articles

£10,000 in savings? I’d aim for £633k in FTSE 100 shares and £25k a year of passive income

| Royston Wild

I'm aiming for a blistering second income by prioritising investment in FTSE 100 shares. Here's how this strategy could supercharge…

Read more »

GSK scientist holding lab syringe
Investing Articles

Is the GSK share price too cheap to ignore?

| Dylan Hood

The GSK share price has risen 7% in 2024, but still looks cheap to me. This Fool takes a closer…

Read more »

Young female business analyst looking at a graph chart while working from home
Investing Articles

Is biopharmaceutical company GSK worth buying as a high-income dividend stock?

| Kevin Godbold

The GSK directors are guiding for a dividend rise this year. So does the almost 4% yield make it a…

Read more »

Female Doctor In White Coat Having Meeting With Woman Patient In Office
Investing Articles

Is the GSK share price too low, after another strong set of results?

| Alan Oscroft

The GSK share price has had a weak five years, and strong results for 2023 make me think the market…

Read more »

GSK scientist holding lab syringe
Investing Articles

After GSK’s 11% share price rise, is it too late for me to buy more?

| Simon Watkins

Despite GSK’s share price rising 11% in a year, there appears good value left in them, with a new growth…

Read more »